Announced
Completed
Financials
Sources
Tags
Private
Minority
Completed
Iceland
Friendly
Private Equity
Pharmaceuticals
Venture Capital
Acquisition
Cross Border
drug discovery
Synopsis
KIRKBI, a private holding and investment company, led a $100m Series B funding round in Kerecis, a manufacturer of fish skin-based therapeutic products, with participation from Emerson Collective, BRU and LSV. "Kerecis is a highly innovative company that has built a successful business transforming waste material into unique medical products. We are particularly inspired by the company's approach to sustainability, as we are responsible investors and owners. We are excited to support the company’s continued growth and strategic objectives to improve patient outcomes," Niklas Sjöblom, KIRKBI Senior Director, Long-Term Equity.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.